MA25138A1 - 5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine - Google Patents

5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine

Info

Publication number
MA25138A1
MA25138A1 MA25155A MA25155A MA25138A1 MA 25138 A1 MA25138 A1 MA 25138A1 MA 25155 A MA25155 A MA 25155A MA 25155 A MA25155 A MA 25155A MA 25138 A1 MA25138 A1 MA 25138A1
Authority
MA
Morocco
Prior art keywords
tetrahydropuridine
tatrazole
methyle
ethyl
Prior art date
Application number
MA25155A
Other languages
English (en)
Inventor
Bech Sommer Michael
Nielson Ole
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MA25138A1 publication Critical patent/MA25138A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA25155A 1997-07-01 1998-07-01 5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine MA25138A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
MA25138A1 true MA25138A1 (fr) 2001-04-02

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25155A MA25138A1 (fr) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine

Country Status (25)

Country Link
EP (1) EP0994869A1 (fr)
JP (1) JP2002507215A (fr)
KR (1) KR20010014297A (fr)
CN (1) CN1261361A (fr)
AR (1) AR013096A1 (fr)
AU (1) AU735751B2 (fr)
BG (1) BG103933A (fr)
BR (1) BR9810331A (fr)
CA (1) CA2293324A1 (fr)
CO (1) CO4940483A1 (fr)
EA (1) EA200000081A1 (fr)
HU (1) HUP0002876A2 (fr)
IL (1) IL133093A0 (fr)
IS (1) IS5278A (fr)
JO (1) JO2031B1 (fr)
MA (1) MA25138A1 (fr)
NO (1) NO996580D0 (fr)
PE (1) PE116099A1 (fr)
PL (1) PL337184A1 (fr)
SK (1) SK187399A3 (fr)
TN (1) TNSN98120A1 (fr)
TR (1) TR199903283T2 (fr)
UY (2) UY25069A1 (fr)
WO (1) WO1999001448A1 (fr)
ZA (1) ZA985498B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
AU706594B2 (en) * 1995-11-06 1999-06-17 H. Lundbeck A/S Treatment of traumatic brain injury

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
CO4940483A1 (es) 2000-07-24
CA2293324A1 (fr) 1999-01-14
UY25069A1 (es) 1998-12-21
NO996580L (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
NO996580D0 (no) 1999-12-30
EA200000081A1 (ru) 2000-08-28
JO2031B1 (en) 1999-05-15
AU8102098A (en) 1999-01-25
KR20010014297A (ko) 2001-02-26
ZA985498B (en) 1999-01-20
CN1261361A (zh) 2000-07-26
SK187399A3 (en) 2000-06-12
TNSN98120A1 (fr) 2005-03-15
IS5278A (is) 1999-11-30
EP0994869A1 (fr) 2000-04-26
TR199903283T2 (xx) 2000-06-21
UY25177A1 (es) 2000-12-29
BG103933A (en) 2000-07-31
IL133093A0 (en) 2001-03-19
WO1999001448A1 (fr) 1999-01-14
BR9810331A (pt) 2000-09-05
PL337184A1 (en) 2000-08-14
JP2002507215A (ja) 2002-03-05
AU735751B2 (en) 2001-07-12
AR013096A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK0864582T3 (da) Hypolidemiske 1,4-benzothiazepin-1,1-dioxider
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
FI951772A7 (fi) 3,5-disubstituoidut tetrahydrofuran-2-onit
DK0973746T3 (da) Substituerede 3-cyanoquinoliner
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DK1149106T3 (da) 4,5-azolo-oxindoler
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id) Turunan-turunan 2 deoksi higromisin
ID20352A (id) Bahan herbisida 3,5-difluoropiridin
ES1036909Y (es) Pupitre infantil.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
DK0966464T3 (da) Substituerede 2,4-diaminopyrimidiner
ES1037395Y (es) Tendedero antilluvia.
ES1038172Y (es) "caja-contenedor".
ES1036948Y (es) Carpeta-atril mejorada.
ES1038416Y (es) Gregadero mejorado.
ES1036324Y (es) Cose-papeles mejorado.
ES1038270Y (es) Anillo-grafo.
ES1037502Y (es) Hoja - octavilla perfeccionada.